benjamin maimon

Benjamin Maimon (co-founder) is a PhD student at the Massachusetts Institute of Technology, pursuing a degree in Medical Engineering & Medical Physics from the Harvard-MIT Health Sciences and Technology program. His research focuses on the development of novel Peripheral Nerve Interfaces at MIT Media Lab’s Biomechatronics group.

Benjamin has a broad background in mechanical engineering design and rapid prototyping for the medical device industry. Prior to starting his PhD, Benjamin consulted for medical device start-ups iRhythm Technologies and DC Devices specifically in mechanical design for their cardiology products. He has also worked for Medtronic helping to define the mechanical behavior of their implantable neurological stimulators. 

In addition to mechanical design, Benjamin also has management consulting experience working as an analyst for the private equity practice of Dean & Co. In this role, Benjamin conducted due diligence analyses for acquisitions in a wide range of industries including the biopharmaceutical supply chain, and a $100MM acquisition in the construction materials sector. 

Benjamin graduated from Duke University with a bachelor’s degree in Mechanical Engineering and Biomedical Engineering.




christopher lee

Christopher Lee (co-founder) is a PhD student at Harvard Medical School and the Massachusetts Institute of Technology, within the joint Harvard-MIT Health Sciences and Technology program. Chris currently works underneath Professor Michael J. Cima focusing on translational medical devices. 

He graduated in 2012 from the University of Connecticut with a bachelor’s degree in Biomedical Engineering and concentration in Electrical Engineering. Chris continued on to obtain a master’s degree in Bioengineering Innovation and Design from Johns Hopkins University, a degree catered towards the commercialization of medical devices and biotechnology. 

Chris also has management consulting experience working as an analyst for the Innovation and Technology Management group within Sagentia, where he provided front-end product development and strategy consulting services for medical, industrial, and consumer clients. He also has some experience working in venture capital with RA Capital Management, a Boston based crossover fund investing in the biotechnology space. 

Chris has been nationally recognized for his pursuits in numerous business plan competitions and academic achievements. He has been an author on over a half-dozen publications, and currently holds one patent.




ho-jun suk

Born and raised in Korea, Ho-Jun attended Cornell University and University of Illinois at Urbana-Champaign for his bachelors and masters degrees in Electrical and Computer Engineering. Ho-Jun is currently a Medical Engineering & Medical Physics PhD student in the Harvard-MIT Health Sciences and Technology program. His research is centered in the fields of whole brain imaging and tool development for electrophysiological studies of neurons, working with Professor Ed Boyden at MIT. 

Ho-Jun’s prior research and industry experiences span from high-power LED development to dielectrophoresis-based mammalian cell manipulation to biosensors for detection of pathogenic bacteria. Prior to Recon Therapeutics, Ho-Jun spent nearly two years working for one of the world’s leading LED suppliers, Seoul Semiconductor Co., LTD, where he designed and developed novel high-power LED chips. He also worked at a government-run research institute in Korea for 1.5 years, focusing on the development of low-cost, easy-to-use biosensors for rapid detection of bacteria that cause food poisoning.

Ho-Jun has been awarded numerous fellowships and research awards for his achievements, including Samsung Scholarship and Undergraduate Research Awards. He also has several research publications and patents. 


photo 1.jpg

Jack aguilar

Jack Aguilar is currently a medical student at the Giesel School of Medicine at Dartmouth. He is also currently a William J. von Liebig (renamed T35) Fellow at the Vascular Surgery Division of Beth Israel Deaconess Medical Center, where he is researching the role of monocytes in the development of intimal hyperplasia following various vascular procedures.

Jack graduated from Johns Hopkins University with a bachelor’s degree in Biomedical Engineering. As part of a senior design team, he helped develop a low-cost paper-based microfluidic diagnostic device to test for HIV, Hep B, and Hep C. Jack, along with team member Steffi Liu, represented their device team at the Wake Forest Business Plan Competition, where they placed 3rd in the social track competition. He also co-authored a preliminary patent for the team and their business plan/proposals.

Jack also has consulting experience, having worked as an analyst for Accenture, he analyzed and outlined client business requirements and translated them into technical specifications to be completed by the programming team. He also gained experience in health policy analysis while working at Avalere Health LLC in their financial services branch. At Avalere, Jack analyzed Medicare and Medicaid reimbursement across the United States based on state budget reports, as well as mapped various moves in hospital stocks based on health policy changes at the national level. 



Alex springer

Alex Springer is in the Department of Mechanical Engineering at M.I.T. He brings valuable experience and perspective to design for Recon Therepeutics. His past projects include an anemia diagnostic device for use in rural Nicaraguan healthcare clinics, a concept product for noise-reduction in hospitals and households called Aureus, and a voice-controlled wheelchair named V.I.D.A. Alex’s past experience in medical device design and research stem from internships and research positions at Vecna Technologies, the National Centre for Biological Sciences in Bangalore, India, the MIT Erdman Laboratory for microbes and inflammatory diseases as well as the MIT Yannas Laboratory for Tissue Engineering. He has been recognized as a Tau Beta Pi Engineering fellow, a TATA research fellow and assisted in authoring three scientific publications. Alex contributes to Recon therapeutics through design for manufacturing, supply chain logistics, top-level design, and user experience interfaces.